GlassScriptPhysician profile
John Ritrosky
NPI 1306828124
$571.04
in general payments reported to CMS, 2019-2025
14 companies · $38.14 in 2025
The $38.14 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $31.26 · 2021: $52.35 · 2022: $152 · 2023: $102 · 2024: $17.76 · 2025: $38.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $157.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $120.51 | 2020-2023 | Gardasil 9, Vaxelis, Vaxneuvance |
| Phadia US INC. | $84.09 | 2019 | |
| Corium, LLC | $65.62 | 2022-2023 | Azstarys |
| Ironshore Pharmaceuticals INC. | $54.33 | 2019-2023 | Jornay Pm |
| Merz North America, INC. | $39.56 | 2023 | Xeomin |
| Fisher & Paykel Healthcare INC | $38.14 | 2025 | Fisher & Paykel Healthcare |
| Neos Therapeutics, LP | $37.42 | 2019 | |
| Supernus Pharmaceuticals, INC. | $37.17 | 2021-2022 | |
| Galderma Laboratories, L.P. | $18.43 | 2022 | |
| Cranial Technologies, INC | $17.76 | 2024 | Doc Band |
| Pfizer INC. | $16.22 | 2019 | |
| Tris Pharma INC | $16.13 | 2019 | |
| Sobi, INC | $14.49 | 2022 | |
| Glaxosmithkline, LLC. | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ritrosky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.